Pain & Expert: Global Pain-assessment: a Prospective Registry
1 other identifier
observational
100
1 country
1
Brief Summary
Full assessment of chronic pain patients based on the ICF-model.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2020
CompletedStudy Start
First participant enrolled
March 2, 2020
CompletedFirst Posted
Study publicly available on registry
March 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedMarch 10, 2020
March 1, 2020
12 months
March 2, 2020
March 6, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility of a global pain-assessment (i.e. practical use)
at the time of the assessment: one day (cross-sectional)
Secondary Outcomes (1)
norm values for chronic pain patients on all aspects of the global pain-assessment will be reported (i.e. descriptives)
at the time of the assessment: one day (cross-sectional)
Study Arms (1)
chronic pain patients
Interventions
Eligibility Criteria
Patients with chronic pain.
You may qualify if:
- Patients with chronic pain for at least 3 months
- Age =\> 18 years
- Patient has been informed of the study procedures and has given written informed consent
You may not qualify if:
- Healthy patients or patients with acute pain.
- Addiction to drugs, alcohol (\>5 units per day)
- Evidence of an active disruptive psychiatric disorder that may impact perception of pain, and/or ability to evaluate treatment outcome as determined by investigator
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Moens Maartenlead
Study Sites (1)
Universitair Ziekenhuis Brussel
Jette, Brussels Capital, 1090, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Week
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof. dr.
Study Record Dates
First Submitted
March 2, 2020
First Posted
March 10, 2020
Study Start
March 2, 2020
Primary Completion
March 1, 2021
Study Completion
March 1, 2021
Last Updated
March 10, 2020
Record last verified: 2020-03